Zynerba Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 30th, 2019 • Zynerba Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 30th, 2019 Company Industry JurisdictionZynerba Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co., Canaccord Genuity LLC, H.C. Wainwright & Co., LLC and Ladenburg Thalmann & Co. Inc. (each, an “Agent,” and collectively, the “Agents”), as follows:
August 30, 2019 Armando Anido Dear Armando:Employment Agreement • August 30th, 2019 • Zynerba Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 30th, 2019 Company IndustryAs you know, you and Zynerba Pharmaceuticals, Inc. (the “Company”) are parties to that certain employment agreement dated as of September 4, 2014 (as amended and/or restated from time to time, the “Employment Agreement”). For good and valuable consideration, you and the Company hereby agree to amend the Employment Agreement as follows: